Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 408 participants.
Also called NCT03847883
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 408 participants
- Sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Registry
-
NCT03847883
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Thailand
- Registry status
- Completed
Technical summary
Registry record NCT03847883. Randomized; triple masking; primary purpose treatment. Start 2011-01-01 (actual); primary completion 2018-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low-dose Versus Standard Dose Alteplase in Acute Ischemic Stroke , 4 Monthes Prospective Study
- Condition
- Acute Stroke
- Intervention (Drug)
- Intravenous Solution Ateplase
- Lead sponsor
- Department of Medical Services Ministry of Public Health of Thailand
- Collaborator
- Lumpang Hospital
Record details
- Record id
cardio:ct-nct03847883- Content hash
081c8eeafa71c68d3f12920bd189385009074f49cad31ac507f046f86f73c909